{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:54Z","timestamp":1791409914911,"version":"4.3.3"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/24\/2022-DDI\/BMS"],"award-info":[{"award-number":["45\/24\/2022-DDI\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["SR\/PURSE\/2023\/220(C)"],"award-info":[{"award-number":["SR\/PURSE\/2023\/220(C)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000964","name":"Arthritis National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2023\/000749"],"award-info":[{"award-number":["CRG\/2023\/000749"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110271","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:59:41Z","timestamp":1784559581000},"page":"110271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and evaluation of pyrazole-fused quinoline hybrids as dual-function anticancer and fluorescent live-cell imaging agents"],"prefix":"10.1016","volume":"181","author":[{"given":"Sahil","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Gangwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Ranolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farman","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Sindhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Mantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bioorg.2026.110271_bb0005","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1245\/s10434-022-12151-6","article-title":"GLOBOCAN 2020 report on Global Cancer Burden: challenges and opportunities for surgical oncologists: SVS Deo et al","volume":"29","author":"Deo","year":"2022","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110271_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BCJ20160583","article-title":"Topoisomerases as anticancer targets","volume":"475","author":"Delgado","year":"2018","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110271_bb0015","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/acs.jmedchem.0c01786","article-title":"US FDA approved drugs from 2015\u2013June 2020: a perspective","volume":"64","author":"Bhutani","year":"2021","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110271_bb0020","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1021\/jm401814y","article-title":"Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776)","volume":"57","author":"Beck","year":"2014","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.110271_bb0025","doi-asserted-by":"crossref","first-page":"17572","DOI":"10.1021\/acs.jmedchem.1c01491","article-title":"Design and synthesis of indenoisoquinolines targeting topoisomerase I and other biological macromolecules for cancer chemotherapy","volume":"64","author":"Cushman","year":"2021","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110271_bb0030","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1021\/acs.jmedchem.6b00003","article-title":"Investigation of the structure\u2013activity relationships of aza-A-ring indenoisoquinoline topoisomerase I poisons","volume":"59","author":"Beck","year":"2016","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110271_bb0035","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/acs.jmedchem.6b01565","article-title":"Synthesis and biological evaluation of the first triple inhibitors of human topoisomerase 1, tyrosyl\u2013DNA phosphodiesterase 1 (Tdp1), and tyrosyl\u2013DNA phosphodiesterase 2 (Tdp2)","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110271_bb0040","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1021\/acs.jmedchem.5b00303","article-title":"Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore","volume":"58","author":"Beck","year":"2015","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110271_bb0045","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1021\/jm500294a","article-title":"Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I\u2013tyrosyl-DNA phosphodiesterase I inhibitors","volume":"57","author":"Lv","year":"2014","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110271_bb0050","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1021\/acs.jmedchem.6b01870","article-title":"Design and synthesis of chlorinated and fluorinated 7-azaindenoisoquinolines as potent cytotoxic anticancer agents that inhibit topoisomerase I","volume":"60","author":"Elsayed","year":"2017","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110271_bb0055","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1021\/cr900097c","article-title":"DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition","volume":"109","author":"Pommier","year":"2009","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110271_bb0060","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/nprot.2008.174","article-title":"DNA cleavage assay for the identification of topoisomerase I inhibitors","volume":"3","author":"Dexheimer","year":"2008","journal-title":"Nat. Protoc."},{"issue":"41","key":"10.1016\/j.bioorg.2026.110271_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202301700","article-title":"Design, synthesis, and anticancer evaluation of hemithioindigos via inhibition of human topoisomerases","volume":"8","author":"Kaur","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110271_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103409","article-title":"E-pharmacophore guided discovery of pyrazolo [1, 5-c] quinazolines as dual inhibitors of topoisomerase-I and histone deacetylase","volume":"94","author":"Joshi","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"26","key":"10.1016\/j.bioorg.2026.110271_bb0075","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1002\/slct.202101459","article-title":"Design, synthesis and biological evaluation of new 5-(2-nitrophenyl)-1-aryl-1H-pyrazoles as topoisomerase inhibitors","volume":"6","author":"Kaur","year":"2021","journal-title":"ChemistrySelect"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110271_bb0080","doi-asserted-by":"crossref","first-page":"14880","DOI":"10.1039\/C5RA25705K","article-title":"Synthesis and biological evaluation of new 2, 5-dimethylthiophene\/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors","volume":"6","author":"Joshi","year":"2016","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110271_bb0085","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1016\/j.bmc.2015.07.020","article-title":"Imine\/amide\u2013imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: microwave-assisted synthesis and anticancer activity via selective topoisomerase-II-\u03b1 inhibition","volume":"23","author":"Negi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105114","article-title":"Synthesis of 1, 4-dihydropyrazolo [4, 3-b] indoles via intramolecular C (sp2)-N bond formation involving nitrene insertion, DFT study and their anticancer assessment","volume":"114","author":"Kaur","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110271_bb0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110271_bb0100","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.apsb.2018.07.008","article-title":"Recent developments in topoisomerase-targeted cancer chemotherapy","volume":"8","author":"Hevener","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110271_bb0105","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/14756366.2020.1821676","article-title":"DNA topoisomerases as molecular targets for anticancer drugs","volume":"35","author":"Buzun","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110271_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/13543776.2021.1879051","article-title":"A patent review of topoisomerase I inhibitors (2016\u2013present)","volume":"31","author":"Selas","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110271_bb0115","doi-asserted-by":"crossref","first-page":"553","DOI":"10.13005\/bpj\/2396","article-title":"The DNA-topoisomerase inhibitors in cancer therapy","volume":"15","author":"Mastrangelo","year":"2022","journal-title":"Biomed. Pharmacol. J."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110271_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10311-019-00959-w","article-title":"Chalcone synthesis, properties and medicinal applications: a review","volume":"18","author":"Rammohan","year":"2020","journal-title":"Environ. Chem. Lett."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110271_bb0125","doi-asserted-by":"crossref","first-page":"11617","DOI":"10.1039\/D5RA01280E","article-title":"Excavating medicinal virtues of chalcones to illuminate a new scope in cancer chemotherapy","volume":"15","author":"Nivedya","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110271_bb0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.molstruc.2018.05.010","article-title":"A novel potential anticancer chalcone: synthesis, crystal structure and cytotoxic assay","volume":"1168","author":"Michelini","year":"2018","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110271_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00044-004-0122-7","article-title":"Synthesis and cytotoxic properties of nitro-and aminochalcones","volume":"14","author":"Pati","year":"2005","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110271_bb0140","doi-asserted-by":"crossref","first-page":"20251310","DOI":"10.1515\/med-2025-1310","article-title":"Anticancer activity mechanism of novelly synthesized and characterized benzofuran ring-linked 3-nitrophenyl chalcone derivative on colon cancer cells","volume":"20","author":"Oztepe","year":"2025","journal-title":"Open Med."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110271_bb0145","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1080\/07391102.2024.2301746","article-title":"Design, synthesis, molecular modeling, and biological evaluations of novel chalcone based 4-Nitroacetophenone derivatives as potent anticancer agents targeting EGFR-TKD","volume":"43","author":"Mir","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110271_bb0150","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.3390\/molecules30122498","article-title":"A review of natural and synthetic chalcones as anticancer agents targeting topoisomerase enzymes","volume":"30","author":"Toublet","year":"2025","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.bioorg.2026.110271_bb0155","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.3390\/molecules26237177","article-title":"Chalcone scaffolds, bioprecursors of flavonoids: chemistry, bioactivities, and pharmacokinetics","volume":"26","author":"Rudrapal","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110271_bb0160","first-page":"388","article-title":"Diverse molecular targets for chalcones with varied bioactivities","volume":"5","author":"Zhou","year":"2015","journal-title":"Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110271_bb0165","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/molecules22081210","article-title":"Chalcone derivatives: promising starting points for drug design","volume":"22","author":"Gomes","year":"2017","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110271_bb0170","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1021\/tx100172x","article-title":"Prediction of Michael-type acceptor reactivity toward glutathione","volume":"23","author":"Schw\u00f6bel","year":"2010","journal-title":"Chem. Res. Toxicol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110271_bb0175","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00044-019-02384-8","article-title":"Different reactivity to glutathione but similar tumor cell toxicity of chalcones and their quinolinone analogues","volume":"28","author":"d\u2019Oliveira","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110271_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106560","article-title":"Design and synthesis of uracil\/thiouracil based quinoline scaffolds as topoisomerases I\/II inhibitors for chemotherapy: a new hybrid navigator with DFT calculation","volume":"136","author":"El-Kalyoubi","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110271_bb0185","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0968-0896(98)00030-3","article-title":"Synthesis and inhibitory activity of novel tri-and tetracyclic quinolines against topoisomerases","volume":"6","author":"Sui","year":"1998","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110271_bb0190","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1349-7006.1997.tb00320.x","article-title":"Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II","volume":"88","author":"Utsugi","year":"1997","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110271_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138519","article-title":"Synthesis, molecular docking and pharmacological studies of novel quinoline derivative as anticancer agent that targets topoisomerase IIB","volume":"1312","author":"Suresh","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110271_bb0200","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1021\/acs.jmedchem.8b01938","article-title":"Discovery and mechanistic study of tailor-made quinoline derivatives as topoisomerase 1 poison with potent anticancer activity","volume":"62","author":"Kundu","year":"2019","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110271_bb0205","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1021\/jm00047a008","article-title":"Synthesis and structure-activity relationship of methyl-substituted indolo [2, 3-b] quinolines: novel cytotoxic, DNA topoisomerase II inhibitors","volume":"37","author":"Peczynska-Czoch","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2018.02.058","article-title":"Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity","volume":"149","author":"Alonso","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110271_bb0215","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/S0968-0896(99)00200-X","article-title":"Synthesis, and cytotoxic activity of some novel indolo [2, 3-b] quinoline derivatives: DNA topoisomerase II inhibitors","volume":"7","author":"Kaczmarek","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0220","doi-asserted-by":"crossref","first-page":"118422","DOI":"10.1016\/j.bmc.2025.118422","article-title":"Synthesis, in-silico and in-vitro evaluation of quinoline-chromene hybrids as dual topoisomerase inhibitors","volume":"131","author":"Saxena","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110271_bb0225","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bmc.2019.01.011","article-title":"Synthesis and biological evaluation of pyrazole linked benzothiazole-\u03b2-naphthol derivatives as topoisomerase I inhibitors with DNA binding ability","volume":"27","author":"Nagaraju","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2018.07.059","article-title":"Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: design, synthesis and antibacterial activity","volume":"157","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103132","article-title":"Thiohydantoin derivatives incorporating a pyrazole core: design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anticancer and anti-inflammatory activities","volume":"91","author":"Abdellatif","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110271_bb0240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/ph15040399","article-title":"Design, synthesis, and cytotoxicity and topoisomerase I\/II\u03b1 inhibition activity of pyrazolo [4, 3-f] quinoline derivatives","volume":"15","author":"Chaudhary","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110271_bb0245","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/molecules23051036","article-title":"Discovery of pyrazolo [4, 3-c] quinolines derivatives as potential anti-inflammatory agents through inhibiting of NO production","volume":"23","author":"Tseng","year":"2018","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110271_bb0250","first-page":"486","article-title":"A convenient synthesis of new substituted pyrazolo [4, 3-c] quinolines with potential antiinflammatory activity","volume":"49","author":"Mekheimer","year":"1994","journal-title":"Pharmazie"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110271_bb0255","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1021\/acs.jmedchem.7b00963","article-title":"Specific inhibition of bacterial \u03b2-glucuronidase by pyrazolo [4, 3-c] quinoline derivatives via a pH-dependent manner to suppress chemotherapy-induced intestinal toxicity","volume":"60","author":"Cheng","year":"2017","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110271_bb0260","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/cr078381n","article-title":"BODIPY dyes and their derivatives: syntheses and spectroscopic properties","volume":"107","author":"Loudet","year":"2007","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110271_bb0265","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/cr300508p","article-title":"Design strategies for water-soluble small molecular chromogenic and fluorogenic probes","volume":"114","author":"Li","year":"2014","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110271_bb0270","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1039\/C7CS00907K","article-title":"Fluorogenic probes for disease-relevant enzymes","volume":"48","author":"Zhang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.110271_bb0275","article-title":"Dual-emissive ratiometric \u201cturn-on\u201d probe for real-time sensing of HSO4\u2212 in environmental samples and live cells","volume":"344","author":"Ranolia","year":"2025","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110271_bb0280","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1039\/C4CS00051J","article-title":"Macro-\/micro-environment-sensitive chemosensing and biological imaging","volume":"43","author":"Yang","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110271_bb0285","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bmcl.2018.01.023","article-title":"Iodine mediated pyrazolo-quinoline derivatives as potent antiproliferative agents","volume":"28","author":"Kasaboina","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110271_bb0290","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1080\/00397911.2022.2114372","article-title":"Acid-promoted synthesis of pyrazolo [4, 3-c] quinoline derivatives by employing pyrazole-arylamines and \u03b2-keto esters via cleavage of C\u2013C bonds","volume":"52","author":"Jiang","year":"2022","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.110271_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2022.133040","article-title":"Acid-catalyzed synthesis of pyrazolo [4, 3-c] quinolines from (1H-pyrazol-5-yl) anilines and ethers via the cleavage of C\u2013O bond","volume":"125","author":"Mu","year":"2022","journal-title":"Tetrahedron"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110271_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202104337","article-title":"Synthesis of fused pyrazolo [4, 3-c] quinolines through KI-promoted cyclization of pyrazole-arylamines and benzyl bromide","volume":"7","author":"Mu","year":"2022","journal-title":"ChemistrySelect"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110271_bb0305","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jhet.4420","article-title":"Construction of substituted pyrazolo [4, 3-c] quinolines via [5+ 1] cyclization of pyrazole-arylamines with alcohols\/amines in one pot","volume":"59","author":"Tang","year":"2022","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0310","first-page":"116979","article-title":"Visible-light-driven redox coupling strategy for the synthesis of pyrazolo [4, 3-c] quinoline via reusable CdS nanoparticles as photocatalyst","volume":"474","author":"Shanthi","year":"2025","journal-title":"J. Photochem. Photobiol. A Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110271_bb0315","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s13046-019-1353-2","article-title":"Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110271_bb0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jmb.2008.03.052","article-title":"Unusual role of a cysteine residue in substrate binding and activity of human AP-endonuclease 1","volume":"379","author":"Mantha","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110271_bb0325","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.dnarep.2006.10.010","article-title":"Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein","volume":"6","author":"Mitra","year":"2007","journal-title":"DNA Repair"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110271_bb0330","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1093\/nar\/gki641","article-title":"Analysis of nuclear transport signals in the human apurinic\/apyrimidinic endonuclease (APE1\/Ref1)","volume":"33","author":"Jackson","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110271_bb0335","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0500986102","article-title":"Two essential but distinct functions of the mammalian abasic endonuclease","volume":"102","author":"Izumi","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110271_bb0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cbf.3100","article-title":"A review on protein\u2013protein interaction network of APE1\/Ref-1 and its associated biological functions","volume":"33","author":"Thakur","year":"2015","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bioorg.2026.110271_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108861","article-title":"Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: rational design, synthesis, and multi-level characterization","volume":"164","author":"G\u00fcle\u00e7","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108788","article-title":"N-substituted phthalimide-carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: synthesis, mechanistic insights, and cancer-relevant profiling","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110271_bb0355","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13065-023-01063-5","article-title":"Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3\/7 and \u03b2-tubulin polymerization","volume":"17","author":"Alzamami","year":"2023","journal-title":"BMC Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108043","article-title":"Design, synthesis and anticancer evaluation of 4-substituted 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as dual topoisomerase I and II inhibitors","volume":"154","author":"Arora","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110271_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1231030","article-title":"Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3-carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma","volume":"11","author":"Radwan","year":"2023","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110271_bb0370","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/acs.jmedchem.1c00981","article-title":"A perspective on medicinal chemistry approaches for targeting pyruvate kinase M2","volume":"65","author":"Arora","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110271_bb0375","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1038\/s41467-022-33575-4","article-title":"Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry","volume":"13","author":"Dixon","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110271_bb0380","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2174\/2589977511666190912154817","article-title":"In-silico design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer","volume":"11","author":"Kalirajan","year":"2019","journal-title":"Curr. Drug Res. Rev. Formerly: Curr. Drug Abuse Rev."},{"key":"10.1016\/j.bioorg.2026.110271_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103576","article-title":"Design, synthesis and ADMET prediction of bis-benzimidazole as anticancer agent","volume":"96","author":"Rashid","year":"2020","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:15:36Z","timestamp":1791407736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":77,"alternative-id":["S0045206826008072"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110271","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of pyrazole-fused quinoline hybrids as dual-function anticancer and fluorescent live-cell imaging agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110271"}}